The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Jiangsu Hengrui Pharmaceuticals
Neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer: A pilot trial.
 
Jinqi Xue
No Relationships to Disclose
 
Nan Niu
No Relationships to Disclose
 
Shuo Wang
No Relationships to Disclose
 
Guanglei Chen
No Relationships to Disclose
 
Fang Qiu
No Relationships to Disclose
 
Yi Zhao
No Relationships to Disclose
 
Fei Xing
No Relationships to Disclose
 
Xinyu Zheng
No Relationships to Disclose
 
Wei Tu
No Relationships to Disclose
 
Ke Li
No Relationships to Disclose
 
Hai Zhao
No Relationships to Disclose
 
Meiyue Tang
No Relationships to Disclose
 
Qianshi Xu
No Relationships to Disclose
 
Chao Liu
No Relationships to Disclose
 
Yafei Zhao
No Relationships to Disclose
 
Xiaofan Jiang
No Relationships to Disclose
 
Shiwen Huo
Employment - Jiangsu Hengrui Pharmaceuticals
 
Zheng Pang
No Relationships to Disclose
 
Dianlong Zhang
No Relationships to Disclose
 
Caigang Liu
No Relationships to Disclose